Willie Brown
Foot Surgery · Belleville, ILNPI 1447392972
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 34.1% of the total.
Across 24 payments — averaging $56.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$462
- Kerecis Limited$435
- Averitas Pharma Inc.$241
- Bone Support Inc.$68
- Trice Medical, Inc.$50
- Progenacare Global, LLC$47
- plus $54 from 2 others
What the payments were for
- Food & beverage$1,355100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 9 | $462 |
| Kerecis Limited | 5 | $435 |
| Averitas Pharma Inc. | 3 | $241 |
| Bone Support Inc. | 1 | $68 |
| Trice Medical, Inc. | 1 | $50 |
| Progenacare Global, LLC | 3 | $47 |
| Acera Surgical, Inc. | 1 | $42 |
| Melinta Therapeutics, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$1,015
- Kerecis SurgiClose$519
- Kerecis Omega3 SurgiClose$254
- Qutenza$227
- Kerecis GraftGuide$130
- VERSAJET II$125
- Versajet$121
How this compares
$1,355 in reported general payments places this provider in the 55th percentile of 51 foot surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nystatin | 1,088 | $17,649 |
| Clotrimazole | 42 | $1,379 |
| Cephalexin | 37 | $205 |
| Triamcinolone Acetonide | 24 | $157 |
| Doxycycline Hyclate | 13 | $134 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Belleville
- Kim ReichertBelleville$164
- Jeeten SinghaWestmont$14K
- Christopher AndersonO'Fallon$13K
- Stephanie WuNorth Chicago$7K
- Jillian CabaiChicago$7K
- William FinnOak Park$5K
- Jeremiah BushmakerGalesburg$5K
- Cory JacobyElgin$4K
- Syed HussainHoffman Estates$4K
- Edward UramDowners Grove$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.